Peripheral Neuropathy Treatment Springfield Lakes: Comprehensive Nerve Care 2025

Experiencing numbness, tingling, or nerve pain? Peripheral neuropathy affects 2.4% of the population and up to 8% of people over 55. Early diagnosis and treatment can prevent progression and significantly improve symptoms.

Understanding Peripheral Neuropathy

Peripheral neuropathy refers to damage or dysfunction of the peripheral nerves—those outside the brain and spinal cord. These nerves carry information between the central nervous system and the rest of the body.

Types of Peripheral Nerves

Nerve Type	Function	Symptoms When Damaged
Motor Nerves	Muscle movement	Weakness, muscle wasting, cramps
Sensory Nerves	Touch, temperature, pain	Numbness, tingling, burning pain
Autonomic Nerves	Organ function	Heart rate, digestion, blood pressure changes

Classification by Distribution

Mononeuropathy:

Single nerve affected – carpal tunnel, Bell’s palsy
Usually traumatic – compression, injury
Focal symptoms – specific nerve distribution
Better prognosis – often recoverable

Polyneuropathy:

Multiple nerves – bilateral, symmetric
Systemic causes – diabetes, toxins, autoimmune
Distal predominance – hands and feet first
Progressive course – gradual worsening

Mononeuropathy Multiplex:

Multiple single nerves – asymmetric pattern
Vascular causes – diabetes, vasculitis
Stepwise progression – different nerves at different times
Variable recovery – depends on underlying cause

Pathological Classifications

Axonal Neuropathy:

Nerve fiber damage – axon degeneration
Common causes – diabetes, toxins, metabolic
Slower recovery – axon regeneration needed
Sensory predominant – often painful

Demyelinating Neuropathy:

Myelin sheath damage – nerve insulation lost
Autoimmune causes – CIDP, GBS
Conduction slowing – nerve signal delays
Better recovery potential – remyelination possible

Causes and Risk Factors

Common Causes

Category	Specific Causes	Prevalence
Diabetes	Type 1 and Type 2 diabetes	30% of neuropathy
Autoimmune	CIDP, GBS, vasculitis	10% of cases
Toxic	Alcohol, chemotherapy, medications	15% of cases
Infectious	HIV, hepatitis, Lyme disease	5% of cases
Hereditary	CMT, hereditary neuropathies	10% of cases
Idiopathic	Unknown cause	30% of cases

Metabolic Causes

Diabetes mellitus – most common cause
Hypothyroidism – slowed metabolism
Vitamin deficiencies – B1, B6, B12, E
Renal failure – uremic toxins
Liver disease – metabolic dysfunction

Toxic Exposures

Alcohol – direct nerve toxicity
Chemotherapy – cisplatin, vincristine, paclitaxel
Medications – phenytoin, amiodarone, statins
Heavy metals – lead, mercury, arsenic
Industrial chemicals – solvents, pesticides

Autoimmune Conditions

Chronic inflammatory demyelinating polyneuropathy (CIDP)
Guillain-Barré syndrome (GBS)
Vasculitis – nerve blood vessel inflammation
Rheumatoid arthritis – inflammatory joint disease
Systemic lupus erythematosus – multisystem autoimmune

Infectious Causes

HIV – direct viral effect
Hepatitis B and C – immune-mediated
Lyme disease – Borrelia burgdorferi
Cytomegalovirus – immunocompromised patients
Epstein-Barr virus – post-infectious neuropathy

Symptoms and Clinical Presentation

Sensory Symptoms

Numbness – reduced sensation, “glove and stocking”
Tingling – pins and needles sensation
Burning pain – constant, aching discomfort
Sharp, shooting pain – electric shock-like
Allodynia – pain from light touch
Loss of position sense – balance problems

Motor Symptoms

Muscle weakness – progressive loss of strength
Muscle wasting – visible muscle loss
Muscle cramps – painful contractions
Fasciculations – muscle twitching
Foot drop – difficulty lifting foot
Hand weakness – grip strength loss

Autonomic Symptoms

Orthostatic hypotension – dizziness when standing
Gastroparesis – delayed stomach emptying
Constipation – reduced bowel motility
Urinary retention – incomplete bladder emptying
Erectile dysfunction – nerve-related impotence
Hypoglycemia unawareness – in diabetics

Symptom Patterns

Length-Dependent Neuropathy:

Distal onset – starts in feet, progresses proximally
Symmetric – both sides affected equally
“Stocking-glove” distribution – classic pattern
Most common pattern – typical of metabolic causes

Non-Length-Dependent:

Proximal involvement – trunk, face affected
Asymmetric – unequal involvement
Multifocal – scattered nerve involvement
Suggests specific causes – autoimmune, hereditary

Diagnosis and Assessment

Clinical Evaluation

Detailed history – onset, progression, associated symptoms
Medication review – potential neurotoxic drugs
Family history – hereditary neuropathies
Social history – alcohol use, occupational exposures
Systems review – diabetes, kidney, liver disease

Physical Examination

Neurological assessment – strength, sensation, reflexes
Gait evaluation – balance, coordination
Skin examination – trophic changes, ulcers
Muscle examination – wasting, fasciculations
Autonomic testing – blood pressure, heart rate response

Diagnostic Tests

Nerve Conduction Studies (NCS):

Nerve velocity – speed of electrical conduction
Amplitude – nerve signal strength
Latency – delay in nerve response
Demyelinating vs axonal – pattern differentiation

Electromyography (EMG):

Muscle activity – denervation patterns
Motor unit analysis – nerve regeneration
Spontaneous activity – fibrillations, fasciculations
Recruitment patterns – muscle activation

Laboratory Tests:

Test	Purpose	Abnormal Results
Glucose, HbA1c	Diabetes screening	Elevated blood sugar
Vitamin B12	Deficiency detection	<200 pg/mL
TSH	Thyroid function	Elevated TSH
Creatinine	Kidney function	Elevated creatinine
ANA, RF	Autoimmune screening	Positive antibodies
SPEP, UPEP	Paraprotein detection	Monoclonal proteins

Specialized Tests:

Nerve biopsy – rare, for specific diagnoses
Skin biopsy – small fiber neuropathy
Genetic testing – hereditary neuropathies
CSF analysis – inflammatory neuropathies

Treatment Approaches

Treat Underlying Causes

Diabetes control – optimal glucose management
Vitamin supplementation – B12, thiamine, folate
Thyroid replacement – hypothyroidism treatment
Immunosuppression – autoimmune neuropathies
Toxin avoidance – alcohol cessation, medication changes

Neuropathic Pain Management

First-Line Medications:

Drug Class	Examples	Starting Dose	Maximum Dose
Anticonvulsants	Pregabalin, Gabapentin	75mg BID, 300mg daily	300mg BID, 3600mg daily
Antidepressants	Duloxetine, Amitriptyline	30mg daily, 10mg HS	60mg daily, 150mg HS
Topical	Lidocaine 5%, Capsaicin	Apply 2-3 times daily	Up to 3 patches/day

Mechanism of Action:

Anticonvulsants – calcium channel blockade
Antidepressants – serotonin/norepinephrine reuptake inhibition
Topical agents – local nerve blockade

Second-Line Options:

Tramadol – dual mechanism analgesic
Tapentadol – norepinephrine reuptake inhibitor/opioid
Tricyclic antidepressants – older agents with more side effects
Anticonvulsants – lamotrigine, oxcarbazepine

Non-Pharmacological Treatments

Physical Therapy:

Strength training – maintain muscle function
Balance training – fall prevention
Gait training – walking safety
Range of motion – prevent contractures
Functional training – activities of daily living

Occupational Therapy:

Adaptive equipment – assistive devices
Home modifications – safety improvements
Splinting – joint protection
Energy conservation – fatigue management
Vocational rehabilitation – work modifications

Complementary Therapies:

Acupuncture – pain reduction
TENS units – electrical stimulation
Massage therapy – circulation improvement
Yoga, tai chi – balance, flexibility
Alpha-lipoic acid – antioxidant supplement

Specific Neuropathy Types

Diabetic Peripheral Neuropathy

Most common cause – 50% of diabetics
Length-dependent – distal, symmetric
Mixed sensorimotor – pain and weakness
Prevention – optimal glucose control
Management – pain medications, foot care

Chemotherapy-Induced Neuropathy

Platinum compounds – cisplatin, oxaliplatin
Taxanes – paclitaxel, docetaxel
Vinca alkaloids – vincristine, vinblastine
Dose-dependent – cumulative toxicity
Prevention – dose modification, neuroprotective agents

Alcoholic Neuropathy

Direct toxicity – alcohol and metabolites
Nutritional deficiency – thiamine, B12
Length-dependent – sensory predominant
Treatment – alcohol cessation, vitamin replacement
Prognosis – improvement possible with abstinence

Hereditary Neuropathies

Charcot-Marie-Tooth disease – most common hereditary
Progressive – slowly worsening
Family history – genetic pattern
Genetic testing – confirms diagnosis
Management – supportive care, orthoses

Complications and Management

Foot Complications

Ulcers – loss of protective sensation
Infections – delayed healing
Charcot joints – joint destruction
Amputations – severe complications
Prevention – daily foot care, proper footwear

Falls and Injuries

Balance problems – proprioceptive loss
Muscle weakness – reduced stability
Home modifications – safety improvements
Assistive devices – canes, walkers
Balance training – fall prevention programs

Functional Disability

Hand function – fine motor skills
Walking ability – mobility limitations
Work capacity – occupational impact
Independence – activities of daily living
Quality of life – psychological effects

Living with Peripheral Neuropathy

Daily Management

Medication adherence – consistent pain control
Foot inspection – daily examination
Temperature awareness – avoid burns, frostbite
Proper footwear – well-fitting, protective shoes
Regular exercise – maintain strength, balance

Safety Measures

Home lighting – adequate illumination
Bathroom safety – grab bars, non-slip surfaces
Kitchen precautions – temperature checks
Driving assessment – pedal sensation
Medical alert – emergency information

Emotional Support

Depression screening – common comorbidity
Anxiety management – fear of progression
Support groups – peer connections
Counseling – coping strategies
Family education – understanding, support

Prognosis and Recovery

Factors Affecting Outcome

Underlying cause – treatable vs. progressive
Nerve type affected – axonal vs. demyelinating
Severity at diagnosis – extent of damage
Age – younger patients recover better
Treatment response – early intervention important

Recovery Patterns

Neuropathy Type	Recovery Potential	Timeframe
Acute (GBS)	Good	6-24 months
Toxic	Variable	6-18 months
Metabolic	Stabilization	Ongoing
Hereditary	Progressive	Lifelong
Idiopathic	Variable	Unpredictable

Monitoring Progress

Symptom tracking – pain, function scales
Nerve conduction – repeat testing
Functional assessment – activities of daily living
Quality of life – validated instruments
Complications – foot problems, falls

When to Seek Emergency Care

Immediate Medical Attention:

Acute weakness – rapid progression (hours to days)
Breathing difficulties – respiratory muscle involvement
Severe autonomic symptoms – blood pressure instability
New foot ulcer – infection risk
Signs of infection – fever, drainage, odor

Urgent Evaluation Needed:

Progressive weakness – worsening over weeks
Severe pain – uncontrolled with medications
Balance problems – increased fall risk
New symptoms – different pattern
Medication side effects – intolerable effects

Take Action: Neuropathy Care

Don’t let peripheral neuropathy limit your life. Health Hub Springfield Lakes provides comprehensive peripheral neuropathy evaluation and management.

Book Your Neuropathy Assessment

Online booking: Available 24/7 at healthhubspringfieldlakes.com.au/
Phone booking: Call +61 7 3778 4888
Comprehensive evaluation: Nerve function testing and examination
Treatment planning: Personalized neuropathy management

Address: 18 Springfield Lakes Blvd, Springfield Lakes QLD 4300
Your trusted partner for peripheral neuropathy care and neurological wellness.

Medical References

Martyn CN, Hughes RAC. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997;62(4):310-318.
England JD, Gronseth GS, Franklin G, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Neurology. 2009;72(2):185-192.
Therapeutic Guidelines Limited. Neurology: Peripheral neuropathy. In: eTG complete. Melbourne: Therapeutic Guidelines Limited; 2021.
Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173.
Australian Government Department of Health. Medicare Benefits Schedule: Neurology services. Canberra: Commonwealth of Australia; 2021.
Callaghan BC, Kerber KA, Lisabeth LL, et al. Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy. JAMA Neurol. 2014;71(9):1143-1149.
National Institute for Health and Care Excellence. Neuropathic pain in adults: pharmacological management in non-specialist settings. NICE guideline CG173. London: NICE; 2013.
Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneap Minn). 2014;20(5 Peripheral Nervous System Disorders):1293-1306.
Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 9th ed. Melbourne: RACGP; 2018.
Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817-824.

Medical Disclaimer: This information is for educational purposes and does not replace professional medical advice. If you’re experiencing symptoms of peripheral neuropathy, please consult a healthcare professional promptly. Health Hub Springfield Lake’s medical team provides comprehensive peripheral neuropathy assessment and management.